We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Next Gen CBC and Sepsis Diagnostic System Targets Faster, Earlier, Easier Results

By LabMedica International staff writers
Posted on 28 Oct 2024

Every hour is critical in protecting patients from infections, yet there are currently limited tools to assist in early diagnosis before patients reach a hospital. More...

The complete blood count (CBC) is a common blood test that screens for various conditions, including anemia, infection, leukemia, and bleeding. It measures the levels of red and white blood cells as well as platelets. Now, an enhanced diagnostic system aims to provide lab-quality results at lab-grade costs at the patient’s side for this frequently ordered test, which serves as the first line of triage. This system intends to be the most comprehensive patient-side CBC and the first to report immature granulocytes and the neutrophil-to-lymphocyte ratio in community settings, such as physician offices, cancer centers, and ambulances, facilitating earlier identification and triage of severe infections.

Ad Astra Diagnostics (AAD, Morrisville, NC, USA) is developing the user-friendly QScout CBC to deliver quicker CBC test results and enable the earlier detection of severe infections, including sepsis. The QScout CBC measures immature granulocytes, which are early markers of sepsis. AAD's QScout CBC system is being created as the next generation of the company’s QScout RLD, which received 510(k) clearance from the U.S. Food and Drug Administration (FDA) following successful field trials that compared it to central lab tests.

The QScout CBC system will incorporate various enhancements, such as a smaller physical footprint and broader diagnostic capabilities, including faster and more straightforward CBC testing. This innovative system is essentially a "lab in a box," as it contains a computer, microscope, camera, and robotics. To conduct a test, the user simply places a blood sample obtained from a finger stick or venous draw onto a low-cost test cartridge and inserts it into the QScout Lab. There is no need for sample preparation. The system then utilizes artificial intelligence-trained algorithms to identify cells and cellular parameters, providing a test result in approximately two minutes.

"Coupling a full CBC with a sepsis risk score on a small, simple and rugged platform expands the market and increases access to on-site critical testing and early identification of severe illness and sepsis to help prevent unnecessary deaths from infection," said Joy Parr Drach, CEO of AAD.

Related Links:
Ad Astra Diagnostics


New
Gold Member
Latex Test
SLE-Latex Test
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Silver Member
Cell and Tissue Culture Plastics
Diamond® SureGro™ Cell and Tissue Culture Plastics
New
UHF RFID Tag & Inlay
AD-327 U9 ETSI Pure 95
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Ear wax could be a possible screening medium for Parkinson’s disease (Photo courtesy of 123RF)

Earwax Test Accurately Detects Parkinson’s by Identifying Odor Molecules

Current tests for Parkinson’s disease (PD) rely heavily on clinical scales and neuroimaging, which are often subjective, expensive, and ill-suited for routine screening. Since most treatments only slow... Read more

Molecular Diagnostics

view channel
Image: Capsule sponge opened to reveal the sponge (Photo courtesy of StillVision)

Capsule Sponge Test Could Replace Endoscopies for Monitoring Esophageal Cancer Risk

Esophageal cancer remains a challenging disease to treat, with fewer than 20% of patients surviving beyond five years of diagnosis—a statistic that has remained largely unchanged for decades.... Read more

Immunology

view channel
Image: The new tool shines a light on elusive genomic patterns (Photo courtesy of Adobe Stock)

Computational Tool Exposes Hidden Cancer DNA Changes Influencing Treatment Resistance

Structural changes in tumor DNA are among the most damaging genetic alterations in cancer, yet they often go undetected, particularly when tissue samples are degraded or of low quality. These hidden genomic... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.